Brief: Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds
02/12/2024 13:18
Dec 2 (Reuters) - Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES ANNOUNCES NEW U.S. PATENTS SUPPORTING
EVM301
SERIES AND EVM201 SERIES COMPOUNDS
Source text: ID:nBw3qwljJa
Further company coverage: ENVB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003